Subjects: Government Regulation - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Government Regulation ✖

1. 340B Drug Discount Program: oversight of the Intersection with the Medicaid Drug Rebate Program needs improvement : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, January 2020
Subject(s):: Drug Costs -- legislation & jurisprudence
Government Regulation
Medicaid -- economics
United States
United States. Department of Health and Human Services

2. ACF cannot ensure that all child victims of abuse and neglect have court representation

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021
Subject(s):: Child Abuse -- legislation & jurisprudence
Child Protective Services -- standards
Government Regulation
Legal Services -- organization & administration
United States
United States. Department of Health and Human Services

3. ACF should improve oversight of head start to better protect children’s safety

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Child Health
Government Regulation
Early Intervention, Educational
United States
United States. Administration for Children and Families

4. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

Publication:: Washington, DC : United States Government Accountability Office, December 2022
Subject(s):: Elder Abuse -- legislation & jurisprudence
Government Regulation
Hospice Care -- legislation & jurisprudence
Legislation, Medical
Mandatory Reporting
Medicaid -- organization & administration
Medicare -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

5. Achieving the right balance: privacy and security policies to support electronic health information exchange

Publication:: Oakland, Calif. : California HealthCare Foundation, [2012]
Subject(s):: Computer Security
Electronic Health Records
Privacy
Government Regulation
Information Dissemination
Medical Informatics -- legislation & jurisprudence
Humans
California
United States

6. Action level for inorganic arsenic in apple juice: guidance for industry

Publication:: College Park, MD : Center for Food Safety and Applied Nutrition, June 2023
Subject(s):: Arsenic
Food Safety
Food Supply
Government Regulation
United States

7. Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2022
Subject(s):: Biological Products
Drug Development -- legislation & jurisprudence
Government Regulation
Leukemia, Myeloid, Acute -- drug therapy
United States
United States. Food and Drug Administration

8. Addressing the direct care workforce shortage: a bipartisan call to action

Publication:: Washington, DC : Bipartisan Policy Center, December 2023
Subject(s):: Emigrants and Immigrants
Government Regulation
Health Policy
Health Workforce
Home Care Services
Home Health Aides
Home Health Nursing
Medicare
United States

9. Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States

10. Adverse events in hospitals. A quarter of Medicare patients experienced harm in October 2018

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2022
Subject(s):: Government Regulation
Hospitals
Medicare
Patient Harm -- prevention & control
Patient Harm -- statistics & numerical data
Patient Safety
United States

11. Adverse events toolkit. Clinical guidance for identifying harm

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Subject(s):: Evaluation Studies as Topic
Government Regulation
Medical Errors
Patient Harm
Risk Management
United States

12. Adverse events toolkit. Medical record review methodology

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
Subject(s):: Evaluation Studies as Topic
Government Regulation
Medical Errors
Medical Records
Patient Harm
Risk Management
United States

13. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

Publication:: Washington, D.C. : U.S. Government Accountability Office, July 2017
Subject(s):: Air Ambulances -- economics
Fees and Charges
Insurance Coverage -- economics
Cost Sharing
Data Collection
Disclosure
Government Regulation
Humans
United States
United States. Department of Transportation.
Centers for Medicare & Medicaid Services (U.S.)

14. Air travel and communicable diseases: Federal leadership needed to advance research : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, July 2022
Subject(s):: Air Travel
Disease Transmission, Infectious -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Travel-Related Illness -- prevention & control
United States

15. Air travel and communicable diseases: status of research efforts and action still needed to develop federal preparedness plan : testimony before the Subcommittee on Space and Aeronautics, Committee on Science, Space, and Technology, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, June 23, 2020
Subject(s):: Air Travel
Communicable Diseases -- transmission
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Travel-Related Illness
COVID-19 -- transmission
United States

16. Alternative procedures for the manufacture of cold-stored platelets intended for the treatment of active bleeding when conventional platelets are not available or their use is not practical: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, June 2023
Subject(s):: Biological Products -- standards
Blood Platelets
Government Regulation
Platelet Transfusion
Refrigeration
United States

17. Animal use in research: NIH should strengthen oversight of projects it funds at foreign facilities : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, March 2023
Subject(s):: Animal Experimentation -- legislation & jurisprudence
Animal Experimentation -- standards
Government Regulation
International Cooperation -- legislation & jurisprudence
Legislation, Medical
Research -- economics
United States

18. Annual status report information and other submissions for postmarketing requirements and commitments: using forms FDA 3988 and FDA 3989 : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, September 2023
Subject(s):: Forms as Topic
Government Regulation
Product Surveillance, Postmarketing
United States
United States.
United States.

19. Antibiotic resistance: Federal agencies have taken steps to combat the threat, but additional actions needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, April 28, 2023
Subject(s):: Drug Resistance, Microbial
Government Regulation
Legislation, Medical
United States
United States. Department of Health and Human Services

20. Antibiotic resistance: additional federal actions needed to better determine magnitude and reduce impact

Publication:: Washington, DC : United States Government Accountability Office, March 2020
Subject(s):: Bacterial Infections -- therapy
Drug Resistance, Bacterial
Diagnostic Techniques and Procedures
Epidemiological Monitoring
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

21. Antimicrobial susceptibility test (AST) system devices: updating breakpoints in device labeling : guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, September 29, 2023
Subject(s):: Government Regulation
Medical Device Legislation
Microbial Sensitivity Tests -- standards
Product Labeling
United States

22. Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Antiviral Agents -- economics
Antiviral Agents -- supply & distribution
Government Regulation
Legislation, Medical
Pandemic Preparedness
Technology Assessment, Biomedical
United States

23. Application of human factors engineering principles for combination products: questions and answers : guidance for industry and FDA staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, September 2023
Subject(s):: Bioengineering
Device Approval
Drug Development
Drug Industry
Ergonomics
Government Regulation
United States

24. Arkansas Medicaid Fraud Control Unit: 2019 onsite inspection

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):: Forms and Records Control -- standards
Fraud -- legislation & jurisprudence
Government Regulation
Medicaid -- legislation & jurisprudence
Arkansas
United States
United States. Department of Health and Human Services

25. Artificial intelligence in health care: benefits and challenges of machine learning technologies for medical diagnostics : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2022
Subject(s):: Artificial Intelligence -- legislation & jurisprudence
Diagnosis, Computer-Assisted -- legislation & jurisprudence
Government Regulation
Health Policy
Legislation, Medical
United States

26. Assessing the California Children's Services Program

Publication:: Oakland, Calif. : California HealthCare Foundation, [2009]
Subject(s):: Child Health Services -- organization & administration
Medical Assistance
Adolescent
Child
Child, Preschool
Eligibility Determination
Financing, Government
Government Regulation
Health Services Accessibility
Infant
Infant, Newborn
Insurance Coverage
Insurance, Health
Young Adult
Humans
California

27. Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, November 17, 2023
Subject(s):: Computer Simulation
Device Approval
Government Regulation
United States

28. Assessing the effects of food on drugs in INDs and NDAs: clinical pharmacology considerations

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, June 2022
Subject(s):: Administration, Oral
Drug Approval
Drugs, Investigational
Food-Drug Interactions
Government Regulation
United States
United States. Food and Drug Administration

29. Assez!!: la pharmacie est une cible facile pour le gouvernment

Publication:: [France : s.n., 198-?]
Subject(s):: Pharmacies -- legislation & jurisprudence
Government Regulation
France

30. Assisted living in unlicensed housing: the regulatory experience of four states

Publication:: Washington, D.C. : AARP Public Policy Institute, c2007
Subject(s):: Assisted Living Facilities
Government Regulation
Housing
Consumer Behavior
Licensure
Medicaid
Patient Rights
Quality of Health Care
State Government
Humans
Connecticut
Minnesota
New Jersey
North Carolina
United States

31. Attention, le service du médicament est en danger

Publication:: [France : s.n., 198-]
Subject(s):: Pharmacies -- legislation & jurisprudence
Government Regulation
Quality of Health Care
France

32. Awaiting new Medicaid managed care rules: key issues to watch

Author(s):: Paradise, Julia, author
Musumeci, MaryBeth, author
Publication:: Menlo Park, CA : Kaiser Commission on Medicaid and the Uninsured, March 2015
Subject(s):: Government Regulation
Managed Care Programs -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
United States

33. Behavioral health and COVID-19: higher-risk populations and related federal relief funding : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, December 2021
Subject(s):: COVID-19 -- psychology
Government Regulation
Mental Health Services -- legislation & jurisprudence
Pandemics -- economics
Vulnerable Populations -- legislation & jurisprudence
United States

34. Behavioral health: Available workforce information and federal actions to help recruit and retain providers : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, October 2022
Subject(s):: Behavioral Medicine -- organization & administration
Behavioral Medicine -- statistics & numerical data
Government Regulation
Health Personnel
Health Workforce -- organization & administration
Health Workforce -- statistics & numerical data
Legislation, Medical
Mental Health Services
Personnel Selection -- organization & administration
Personnel Selection -- statistics & numerical data
United States
United States. Department of Health and Human Services

35. Benefit-risk assessment for new drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):: Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Pharmaceutical Preparations
Risk Assessment
United States

36. Best practices for convening a GRAS panel: guidance for industry

Publication:: College Park, MD : Center for Food Safety and Applied Nutrition, December 2022
Subject(s):: Advisory Committees
Consumer Product Safety
Government Regulation
Legislation, Drug
United States
United States. Food and Drug Administration

37. Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):: Fraud -- prevention & control
Government Regulation
Medicare Part C -- economics
Risk Adjustment -- economics
United States
United States. Department of Health and Human Services

38. Biomedical research: information on federal contributions to remdesivir : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, March 2021
Subject(s):: Antiviral Agents -- economics
COVID-19 -- economics
Drug Development -- legislation & jurisprudence
Government Regulation
United States

39. Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, February 26, 2020
Subject(s):: Anthracosis -- economics
Bankruptcy -- economics
Coal Mining -- legislation & jurisprudence
Government Regulation
United States

40. Black Lung benefits program: continued inaction on coal operator self-insurance increases financial risk to trust fund : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, December 2, 2021
Subject(s):: Anthracosis -- economics
Government Regulation
Insurance, Health -- legislation & jurisprudence
United States

41. The Board of Health of the City of Boston: is it a public nuisance?

Author(s):: Common sense, 1823-1897, author
Publication:: [Boston?] : [publisher not identified], [1881?]
Subject(s):: Sanitation
Government Regulation
Local Government
Boston
Boston (Mass.). Board of Health (1872-1914)

42. Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, September 15, 2023
Subject(s):: Data Collection
Device Approval
Government Regulation
Medical Device Legislation
United States
United States.
United States.

43. Bridging the gaps: state and local strategies for ensuring backup personal care services

Publication:: Washington, D.C. : AARP Public Policy Institute, c2006
Subject(s):: Health Services Accessibility
Home Care Services
Personnel Staffing and Scheduling
Data Collection
Disabled Persons
Government Regulation
Health Workforce
Local Government
Medicaid -- economics
Quality Assurance, Health Care
Registries
State Government
Humans
United States

44. Bureau of Prisons: assessment of health care reentry policies and procedures needed : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, February 2023
Subject(s):: Government Regulation
Legislation, Medical
Medicaid -- organization & administration
Prisoners -- legislation & jurisprudence
Prisons -- organization & administration
Transitional Care -- legislation & jurisprudence
United States
United States. Bureau of Prisons

45. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

46. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2017
Subject(s):: Government Regulation
Security Measures
Toxins, Biological
Federal Government
Laboratories -- standards
Risk Assessment
Risk Management
Humans
United States
United States. Department of Health and Human Services.
Centers for Disease Control and Prevention (U.S.)

47. CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2024
Subject(s):: COVID-19
Data Collection
Government Regulation
Mandatory Reporting
Nursing Homes
United States
Centers for Disease Control (U.S.)

48. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

49. CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: Child Health
Government Programs
Government Regulation
Immunization Programs
Vaccines -- supply & distribution
United States
Centers for Disease Control and Prevention (U.S.)
Vaccines for Children (Program)

50. CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: COVID-19 Testing -- instrumentation
Equipment Failure Analysis
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

51. CDER’s program for the recognition of voluntary consensus standards related to pharmaceutical quality: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, July 2023
Subject(s):: Drug Industry
Government Regulation
Quality Control
Reference Standards
United States
United States. Food and Drug Administration

52. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

53. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021
Subject(s):: Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

54. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

55. CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):: Cost Control
Drug Costs
Drug Industry
Government Regulation
Medicare Part B
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

56. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):: Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

57. CMS should take further action to address states with poor performance in conducting nursing home surveys

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2022
Subject(s):: Government Regulation
Health Care Surveys -- standards
Nursing Homes -- legislation & jurisprudence
Public Reporting of Healthcare Data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

58. CMS use of data on nursing home staffing: progress and opportunities to do more

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021
Subject(s):: Government Regulation
Health Workforce -- legislation & jurisprudence
Nursing Homes -- standards
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

59. CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
Subject(s):: Data Management -- legislation & jurisprudence
Fraud -- prevention & control
Government Regulation
Medicare Part C -- organization & administration
Records -- statistics & numerical data
United States
United States. Department of Health and Human Services

60. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

61. COVID-19 contracting: Indian Health Service used flexibilities to meet increased medical supply needs : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, October 2021
Subject(s):: American Indians or Alaska Natives -- statistics & numerical data
COVID-19 -- ethnology
Equipment and Supplies -- supply & distribution
Government Regulation
United States
United States. Indian Health Service

62. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, September 2022
Subject(s):: COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

63. COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, March 2023
Subject(s):: COVID-19 -- prevention & control
Cross Infection -- prevention & control
Hand Hygiene -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Nursing Homes -- legislation & jurisprudence
United States

64. COVID-19 in nursing homes: HHS has taken steps in response to pandemic, but several GAO recommendations have not been implemented : testimony before the Committee on Finance, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, March 17, 2021
Subject(s):: COVID-19 -- economics
Government Regulation
Nursing Homes -- trends
United States

65. COVID-19 in nursing homes: most homes had multiple outbreaks and weeks of sustained transmission from May 2020 through January 2021 : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, May 2021
Subject(s):: COVID-19 -- epidemiology
Government Regulation
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

66. COVID-19 pandemic: VA provides health care assistance to civilians as part of the federal response : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, May 2021
Subject(s):: COVID-19 -- prevention & control
Disaster Planning -- organization & administration
Government Regulation
United States
United States. Department of Veterans Affairs

67. COVID-19 pandemic: actions needed to improve federal oversight of assistance to individuals, communities, and the transportation industry : testimony before the Committee on Transportation and Infrastructure, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, July 29, 2021
Subject(s):: COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

68. COVID-19 tests drove an increase in total Medicare Part B spending on lab tests in 2020, while use of non-COVID-19 tests decreased significantly

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2021
Subject(s):: Clinical Laboratory Techniques -- economics
COVID-19 Testing -- economics
Government Regulation
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

69. COVID-19. GAO recommendations can help federal agencies better prepare for future public health emergencies

Publication:: Washington, DC : United States Government Accountability Office, July 2023
Subject(s):: Civil Defense -- legislation & jurisprudence
COVID-19
Government Regulation
Legislation, Medical
Public Health Administration -- legislation & jurisprudence
United States Government Agencies
United States

70. COVID-19: Agencies are taking steps to improve future use of Defense Production Act authorities : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, December 2021
Subject(s):: Equipment and Supplies -- economics
Government Regulation
Public Health -- legislation & jurisprudence
COVID-19
United States
United States.
United States. Department of Defense

71. COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees

Publication:: [Washington, DC] : United States Government Accountability Office, April 2022
Subject(s):: COVID-19 -- economics
Fraud -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Routinely Collected Health Data
United States

72. COVID-19: DOD has focused on strategy and oversight to protect military servicemember health : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, June 2021
Subject(s):: COVID-19 -- prevention & control
Government Regulation
Military Personnel -- legislation & jurisprudence
United States

73. COVID-19: FDA took steps to help make tests available; policy for future public health emergencies needed : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, May 2022
Subject(s):: COVID-19 -- prevention & control
COVID-19 Testing -- standards
Government Regulation
Policy Making
Public Health
United States
United States. Food and Drug Administration

74. COVID-19: Federal efforts to provide vaccines to racial and ethnic groups : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, February 2022
Subject(s):: COVID-19 Vaccines -- economics
Government Regulation
Vulnerable Populations -- statistics & numerical data
United States

75. COVID-19: HHS agencies’ planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, November 2021
Subject(s):: COVID-19 Vaccines -- supply & distribution
Government Regulation
United States
United States. Department of Health and Human Services

76. COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, January 2022
Subject(s):: COVID-19 Vaccines -- supply & distribution
Government Regulation
Health Workforce -- legislation & jurisprudence
United States
United States. Department of Defense
United States. Department of Health and Human Services

77. COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, January 2023
Subject(s):: COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Pandemics -- economics
Arizona
Louisiana
Michigan
New Hampshire
Washington
United States. Department of Health and Human Services

78. COVID-19: HHS should clarify agency roles for emergency return of U.S. citizens during a pandemic : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, April 2021
Subject(s):: Disaster Planning -- legislation & jurisprudence
Government Regulation
Travel-Related Illness
United States
United States. Department of Health and Human Services

79. COVID-19: HHS’s collection of hospital capacity data : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, August 2021
Subject(s):: COVID-19 -- economics
Data Analysis
Government Regulation
Surge Capacity -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

80. COVID-19: Information on HHS's public education campaign : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, March 2022
Subject(s):: Education, Public Health Professional
Financial Management -- organization & administration
Government Regulation
Health Promotion -- organization & administration
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
National Institutes of Health (U.S.)

81. COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, June 2022
Subject(s):: Awareness
Civil Defense -- organization & administration
COVID-19
Government Regulation
Pandemics -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

82. COVID-19: Selected states modified meal provision and other Older Americans Act services to prioritize safety : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, December 2021
Subject(s):: Food Services -- economics
Health Services for the Aged -- economics
Home Care Services -- organization & administration
Government Regulation
COVID-19
United States
United States.

83. COVID-19: TSA could better monitor its efforts to reduce infectious disease spread at checkpoints : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, June 2021
Subject(s):: Airports -- legislation & jurisprudence
COVID-19 -- prevention & control
Government Regulation
Travel-Related Illness
United States

84. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

85. COVID-19: VA should assess its oversight of infection prevention and control in community living centers : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, July 2021
Subject(s):: Communicable Disease Control -- legislation & jurisprudence
COVID-19 -- economics
Government Regulation
Nursing Homes -- legislation & jurisprudence
United States
United States. Department of Veterans Affairs

86. COVID-19: brief update on initial federal response to the pandemic : report to Congress

Publication:: Washington, DC : United States Government Accountability Office, August 2020
Subject(s):: COVID-19 -- economics
Financing, Government -- organization & administration
Government Regulation
Health Status Indicators
United States

87. COVID-19: continued attention needed to enhance federal preparedness, response, service delivery, and program integrity : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, July 2021
Subject(s):: COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

88. COVID-19: efforts to increase vaccine availability and perspectives on initial implementation : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, April 2021
Subject(s):: COVID-19 -- economics
COVID-19 Vaccines -- supply & distribution
Government Regulation
United States

89. COVID-19: federal air marshal service should document its response to cases and facilitate access to testing : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, June 2021
Subject(s):: COVID-19 -- prevention & control
Government Regulation
Police -- statistics & numerical data
Travel-Related Illness
United States

90. COVID-19: implementation and oversight of preparedness strategies at Veterans Affairs medical centers : report to Congressional addresses

Publication:: Washington, DC : United States Government Accountability Office, June 2021
Subject(s):: Civil Defense -- legislation & jurisprudence
COVID-19 -- prevention & control
Disaster Planning -- legislation & jurisprudence
Government Regulation
United States
United States. Department of Veterans Affairs

91. COVID-19: opportunities to improve federal response and recovery efforts : report to the Congress

Publication:: Washington, DC : United States Government Accountability Office, June 2020
Subject(s):: COVID-19 -- economics
Government Regulation
Pandemics -- legislation & jurisprudence
United States

92. COVID-19: sustained federal action is crucial as pandemic enters its second year : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, March 2021
Subject(s):: COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

93. COVID-19: urgent actions needed to better ensure an effective federal response : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, November 2020
Subject(s):: COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
United States

94. California's nurse practitioners: how scope of practice laws impact care

Author(s):: Spetz, Joanne, author
Publication:: [Oakland, Calif.] : California Health Care Foundation, September 2018
Subject(s):: Health Workforce -- statistics & numerical data
Nurse Practitioners -- statistics & numerical data
Nurse's Role
Quality of Health Care
Cost-Benefit Analysis
Government Regulation
Health Services Accessibility
Nurse Practitioners -- education
Primary Health Care
State Government
Humans
California
United States

95. Can 1 + 1 = 3?: a look at hybrid insurance products with long-term care insurance

Publication:: Washington, D.C. : AARP Public Policy Institute, c2007
Subject(s):: Insurance -- economics
Insurance, Long-Term Care -- economics
Long-Term Care -- economics
Consumer Behavior
Federal Government
Government Regulation
Insurance, Disability -- economics
Insurance, Life -- economics
Pensions
Psychology
State Government
Taxes
Humans
United States

96. Cancer clinical trial eligibility criteria: available therapy in non-curative settings

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, July 2022
Subject(s):: Clinical Trials as Topic
Government Regulation
Neoplasms -- drug therapy
United States
United States. Food and Drug Administration

97. Cannabis and cannabis-derived compounds: quality considerations for clinical research : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, January 2023
Subject(s):: Cannabis
Drug Development
Government Regulation
Medical Marijuana
United States
United States. Food and Drug Administration

98. Case study: Missouri’s efforts to protect children missing from foster care

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):: Child, Foster -- legislation & jurisprudence
Foster Home Care -- legislation & jurisprudence
Government Regulation
Homeless Youth -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
Missouri
United States
United States. Department of Health and Human Services

99. Cattle disease: speech

Author(s):: McGowan, Jonas Hartzell, 1837-1909, author
Publication:: Washington : [publisher not identified], 1879
Subject(s):: Cattle Diseases -- prevention & control
Communicable Disease Control -- legislation & jurisprudence
Government Regulation
United States

100. Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):: COVID-19
Government Regulation
Hispanic or Latino
Medicare
Telemedicine -- statistics & numerical data
Urban Population
United States

« Previous
Next »
1
2
3
4
5
6
7